Simile Raises $200 Million Series B at $2 Billion Valuation to Expand AI Simulation Platform
Top Picks
Stay Ahead of the Market
Get the latest startup funding, hiring trends and global opportunities delivered to your inbox every week.
Simile Secures $200 Million in Series B Funding
San Francisco-based Simile has raised $200 million in Series B funding at a $2 billion valuation to accelerate the development of its AI-powered human behavior simulation platform.
The round was led by Greenoaks, with participation from returning investor Index Ventures, alongside Hanabi, Bain Capital Ventures, A*, Factory, CVS Health Ventures, and new investor Definition.
Founded by Joon Sung Park, who also serves as CEO, Simile develops AI-powered human behavior foundation models and predictive simulation software that enables organizations to test decisions before real-world deployment.
Building AI Models for Human Behavior Simulation
Simile's platform combines human behavior foundation models with predictive simulation technology to replicate complex social interactions in virtual environments.
The company says its technology enables enterprises to model human behavior and evaluate potential outcomes before implementing decisions in real-world settings.
Its platform is designed for industries including:
Healthcare
Financial services
Media
Expanding AI Models and Enterprise Operations
The newly raised funding will be used to:
Accelerate training of its human behavior foundation models
Expand simulation compute infrastructure
Scale commercial engineering operations
According to the company, Simile currently works with enterprise customers including Wealthfront, maintains a policy research trend-modeling partnership with Gallup, and supports CVS Health in optimizing medication-adherence pilots and identifying hard-to-reach patient populations.
